Evaluation of recurrence rate in Canadian patients with stage II/III HR+/HER2-early breast cancer in the real-world setting

被引：0
|
作者：
Marques, Maud
Gambaro, Karen
Basik, Mark
Saad, Fred
Hassan, Saima Noor
Boudreau, Dominique
Vincent, Francois
St-Hilaire, Eve
Mackay, Helen
Abdelsalam, Mahmoud
Guillemette, Stephanie
Leite, Ricardo
Caron, Marc-Andre
Patel, Chandni
Batist, Gerald
机构：
[1] Exactis Innovat, Montreal, PQ, Canada
[2] Segal Canc Ctr, Montreal, PQ, Canada
[3] Univ Montreal, Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[4] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[5] Hop St Sacrement, Quebec City, PQ, Canada
[6] Ctr Integr Univ Sante & Serv Sociaux, Mauricie Ctr Quebec, Trois Rivieres, PQ, Canada
[7] Ctr Oncol Leon Richard, Moncton, NB, Canada
[8] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, Toronto, ON, Canada
[9] Moncton City Hosp, Moncton, NB, Canada
[10] Novartis Pharmaceut Canada Inc, Dorval, PQ, Canada
[11] Novartis Canada, Toronto, ON, Canada
[12] Novartis Corp, Montreal, PQ, Canada
[13] Jewish Gen Hosp McGill, Segal Canc Ctr, Montreal, PQ, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e23303
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+/HER2-early breast cancer
    Gong, Gyungyub
    Kwon, Mi Jeong
    Han, Jinil
    Lee, Hee Jin
    Lee, Se Kyung
    Lee, Jeong Eon
    Lee, Seon-Heui
    Park, Sarah
    Choi, Jong-Sun
    Cho, Soo Youn
    Ahn, Sei Hyun
    Lee, Jong Won
    Cho, Sang Rae
    Moon, Youngho
    Nam, Byung-Ho
    Nam, Seok Jin
    Choi, Yoon-La
    Shin, Young Kee
    SCIENTIFIC REPORTS, 2017, 7
  • [32] Real-world Treatment Patterns and Outcomes in HR+/HER2+Metastatic Breast Cancer Patients: A National Cancer Database Analysis
    Statler, Abby B.
    Hobbs, Brian P.
    Wei, Wei
    Gupta, Annie
    Blake, Cassann N.
    Nahleh, Zeina A.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [33] Real-world Treatment Patterns and Outcomes in HR+/HER2+ Metastatic Breast Cancer Patients: A National Cancer Database Analysis
    Abby B. Statler
    Brian P. Hobbs
    Wei Wei
    Annie Gupta
    Cassann N. Blake
    Zeina A. Nahleh
    Scientific Reports, 9
  • [34] Outcomes of male patients with HR+/HER2-advanced breast cancer receiving palbociclib in the real-world POLARIS study
    Blum, Joanne L.
    Dicristo, Caroline
    Gordon, David
    Karuturi, Meghan S.
    Oubre, David
    Jepsen, Erin
    Cuevas, Juan
    Lakhanpal, Shailendra
    Montelongo, Monica Z.
    Zhang, Zhe
    Cappelleri, Joseph C.
    Wang, Yao
    Tripathy, Debu
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 203 (03) : 463 - 475
  • [35] Abemaciclib for treating patients with HR+/HER2-metastatic breast cancer: a real-world study in France, Italy and Spain
    Blancas, Isabel
    Grosjean, Jessica
    Pedersini, Rebecca
    Buzzoni, Carlotta
    Sleilaty, Ghassan
    Molero, Alberto
    Tamma, Antonella
    Chouaki, Nadia
    Atienza, Manuel
    Emde, Anna
    Siddi, Sara
    Bayona, Rodrigo Sanchez
    Del Mastro, Lucia
    Fakhouri, Walid
    FUTURE ONCOLOGY, 2024, 20 (31) : 2371 - 2384
  • [36] Socioeconomic Outcomes With Ribociclib in Patients With HR+, HER2-Advanced Breast Cancer (ABC) in UK Real-world Settings
    Hall, P.
    Howell, S.
    Venkitaraman, R.
    Thomson, A.
    Raja, F.
    King, J.
    Michie, C.
    Khan, S.
    Brunt, A. M.
    Gahir, D.
    McAdam, K.
    Cooner, J.
    Kane, N.
    BREAST, 2023, 68 : S47 - S47
  • [37] Real-world treatment of patients with palbociclib for HR+/HER2-advanced/metastatic breast cancer: the Europe IRIS study
    Mycock, Katie
    Zhan, Lin
    Hart, Kieran
    Taylor-Stokes, Gavin
    Milligan, Gary
    Atkinson, Christian
    Mitra, Debanjali
    FUTURE ONCOLOGY, 2021, 18 (03) : 349 - 362
  • [38] Real-world effectiveness and sensitivity of palbociclib plus endocrine therapy in HR+/HER2-patients with metastatic breast cancer
    Li, Jingping
    Zhang, Xiangmei
    Yang, Chao
    Lv, Yalei
    Yang, Hua
    Kong, Xiangshun
    Han, Meng
    Wang, Zunyi
    Ma, Jie
    Han, Jianjun
    Liu, Yunjiang
    MEDICINE, 2021, 100 (44)
  • [39] Real-world safety and effectiveness of ribociclib in Korean patients with HR+/HER2-locally advanced or metastatic breast cancer
    Kim, J. H.
    Chang, M-C.
    Kim, T-H.
    Seo, J. H.
    Kim, J-J.
    Won, H. S.
    Seong, M-K.
    Kang, Y.
    Lee, Y.
    Lee, K-H.
    ANNALS OF ONCOLOGY, 2024, 35 : S1419 - S1420
  • [40] Metastatic HR+/HER2-Breast Cancer Real-World Data support the clinical Benefits of Palbociclib
    Schoellmann, Claudia
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 (1-2)
12345